Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 28th:
ASLAN Pharmaceuticals Limited (ASLN): This clinical-stage oncology-focused biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.3% over the last 60 days.
ASLAN Pharmaceuticals Ltd. Price and Consensus
ASLAN Pharmaceuticals Ltd. price-consensus-chart | ASLAN Pharmaceuticals Ltd. Quote
ASLAN's shares gained 16.9% over the last one month more than S&P 500’s gain of 0.8%. The company possesses a Momentum Score of A.
ASLAN Pharmaceuticals Ltd. Price
ASLAN Pharmaceuticals Ltd. price | ASLAN Pharmaceuticals Ltd. Quote
Abercrombie & Fitch Co. (ANF): This specialty retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.8% over the last 60 days.
Abercrombie & Fitch Company Price and Consensus
Abercrombie & Fitch Company price-consensus-chart | Abercrombie & Fitch Company Quote
Abercrombie's shares gained 19.7% over the last one month. The company possesses a Momentum Score of B.
Abercrombie & Fitch Company Price
Abercrombie & Fitch Company price | Abercrombie & Fitch Company Quote
Advaxis, Inc. (ADXS): This owner and operator of a late-stage biotechnology company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.
Advaxis, Inc. Price and Consensus
Advaxis, Inc. price-consensus-chart | Advaxis, Inc. Quote
Advaxis’ shares gained 26.3% over the last one month. The company possesses a Momentum Score of A.
Advaxis, Inc. Price
Advaxis, Inc. price | Advaxis, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ASLAN Pharmaceuticals Ltd. (ASLN): Free Stock Analysis Report
Abercrombie & Fitch Company (ANF): Free Stock Analysis Report
Advaxis, Inc. (ADXS): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
